share_log

大塚ホールディングス:大塚製薬は、アルツハイマー病による認知症に伴う興奮の補助療法として、日本でレキサルティの追加適応症を取得しました

Otsuka Holdings: Otsuka Obtains Additional Indication for Rexulti in Japan as an Adjunctive Treatment for Agitation Associated with Dementia due to Alzheimer's Disease

JPX ·  Sep 24, 2024 00:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more